Hemab Therapeutics is building a differentiated coagulation franchise targeting underserved rare bleeding disorders. Learn ...

Activation of the immune system has been increasingly recognised to be associated with procoagulatory status in patients with inflammatory rheumatic disease. Changes in endothelial cell and platelet ...

The definition of coagulopathy is “a condition in which the blood's ability to clot is impaired.” However, for some clinicians, the term also covers thrombotic states, and because of the complexity of ...

When a blood vessel is damaged, your body naturally responds to stop bleeding and loss of blood. Hemostasis or stoppage of bleeding occurs in three steps blood vessel constriction, platelet plug ...

Routine coagulation assays are widely performed in laboratories and provide valuable information to the patient’s overall clinical picture. It’s important for laboratorians to know the methodology of ...

Panel A shows thrombin generation, and Panel B shows thrombin inhibition. Examples of the in vitro curves for thrombin generation and inhibition are also shown. Procoagulant factors are represented by ...

The compendium of newly emerging and currently available hemophilia and anticoagulant treatments, while offering new choices for improved patient care, can create significant levels of interference ...

New results from HMB-002 first-in-human data validate proof of mechanism in Von Willebrand disease (VWD), elevating Von Willebrand Factor (VWF) ...

A recent study led by MedUni Vienna provides new insights into the mechanisms of coagulation in people with hemophilia A, the most common form of hemophilia. The research team was able to show that ...